A detailed history of Ars Investment Partners, LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Ars Investment Partners, LLC holds 134,110 shares of CDNA stock, worth $2.08 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
134,110
Previous 151,510 11.48%
Holding current value
$2.08 Million
Previous $1.82 Million 21.89%
% of portfolio
0.15%
Previous 0.22%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

SELL
$7.96 - $12.37 $138,504 - $215,238
-17,400 Reduced 11.48%
134,110 $1.42 Million
Q4 2023

Feb 14, 2024

SELL
$4.9 - $12.86 $1,078 - $2,829
-220 Reduced 0.14%
151,510 $1.82 Million
Q1 2023

Apr 05, 2023

BUY
$8.83 - $17.61 $1.34 Million - $2.67 Million
151,730 New
151,730 $1.39 Million
Q3 2019

Nov 14, 2019

SELL
$20.03 - $40.08 $196,294 - $392,784
-9,800 Closed
0 $0
Q2 2019

Aug 12, 2019

BUY
$25.78 - $39.77 $252,644 - $389,746
9,800 New
9,800 $353,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $830M
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Ars Investment Partners, LLC Portfolio

Follow Ars Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ars Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ars Investment Partners, LLC with notifications on news.